What did DiaSorin pay for Luminex Corporation?

DiaSorin acquired Luminex Corporation for $1.80B in 2021 (22.2x EBITDA), equivalent to 3.70x revenue. Target revenue was approximately $484.0M. Target EBITDA was approximately $81.0M.

What does Luminex Corporation do?

Luminex Corporation is a laboratory services business.

What multiple did DiaSorin pay for Luminex Corporation?

22.2x EBITDA and 3.70x revenue, based on disclosed deal value of $1.80B and disclosed financials.

M&A TRANSACTION · 2021

Luminex Corporation acquired by DiaSorin

$1.80B· 22.2x EBITDA· 3.70x revenue

Target

Luminex Corporation

Acquirer

DiaSorin

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$484.0M

EBITDA

$81.0M

Deal Value

$1.80B

EV/EBITDA

22.2x

Context

This $1.80B acquisition of Luminex Corporation by DiaSorin sits in the laboratory services sub-vertical. The 22.2x EBITDA multiple paid in 2021 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. DiaSorin is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Luminex Corporation acquisition.

Citation: ExitValue.ai. (2021). Luminex Corporation acquired by DiaSorin. https://exitvalue.ai/deals/luminex-corporation-acquired-by-diasorin-fairness-opi